SymBio Pharmaceuticals Statistics
Total Valuation
SYMQY has a market cap or net worth of 46.16 million. The enterprise value is 34.31 million.
Market Cap | 46.16M |
Enterprise Value | 34.31M |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +10.98% |
Shares Change (QoQ) | +3.09% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 45.62M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.67 |
PB Ratio | 2.82 |
P/TBV Ratio | 2.82 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.06 |
EV / Sales | 2.80 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.03 |
Financial Position
The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.55.
Current Ratio | 8.71 |
Quick Ratio | 6.93 |
Debt / Equity | 0.55 |
Debt / EBITDA | n/a |
Debt / FCF | -0.27 |
Interest Coverage | -39.93 |
Financial Efficiency
Return on equity (ROE) is -105.81% and return on invested capital (ROIC) is -53.31%.
Return on Equity (ROE) | -105.81% |
Return on Assets (ROA) | -47.36% |
Return on Invested Capital (ROIC) | -53.31% |
Return on Capital Employed (ROCE) | -117.53% |
Revenue Per Employee | 116,418 |
Profits Per Employee | -299,131 |
Employee Count | 108 |
Asset Turnover | 0.32 |
Inventory Turnover | 2.46 |
Taxes
In the past 12 months, SYMQY has paid 152,486 in taxes.
Income Tax | 152,486 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.85% in the last 52 weeks. The beta is 0.33, so SYMQY's price volatility has been lower than the market average.
Beta (5Y) | 0.33 |
52-Week Price Change | -20.85% |
50-Day Moving Average | 1.16 |
200-Day Moving Average | 1.14 |
Relative Strength Index (RSI) | 3.55 |
Average Volume (20 Days) | 11 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYMQY had revenue of 12.57 million and -32.31 million in losses. Loss per share was -0.69.
Revenue | 12.57M |
Gross Profit | 9.50M |
Operating Income | -29.89M |
Pretax Income | -32.15M |
Net Income | -32.31M |
EBITDA | n/a |
EBIT | -29.89M |
Loss Per Share | -0.69 |
Balance Sheet
The company has 21.16 million in cash and 9.01 million in debt, giving a net cash position of 12.15 million.
Cash & Cash Equivalents | 21.16M |
Total Debt | 9.01M |
Net Cash | 12.15M |
Net Cash Per Share | n/a |
Equity (Book Value) | 16.38M |
Book Value Per Share | 0.34 |
Working Capital | 25.13M |
Cash Flow
In the last 12 months, operating cash flow was -33.21 million and capital expenditures -69,312, giving a free cash flow of -33.28 million.
Operating Cash Flow | -33.21M |
Capital Expenditures | -69,312 |
Free Cash Flow | -33.28M |
FCF Per Share | n/a |
Margins
Gross margin is 75.52%, with operating and profit margins of -237.71% and -256.95%.
Gross Margin | 75.52% |
Operating Margin | -237.71% |
Pretax Margin | -255.73% |
Profit Margin | -256.95% |
EBITDA Margin | n/a |
EBIT Margin | -237.71% |
FCF Margin | n/a |
Dividends & Yields
SYMQY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.98% |
Shareholder Yield | -10.98% |
Earnings Yield | -69.99% |
FCF Yield | -72.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SYMQY has an Altman Z-Score of -10.51. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -10.51 |
Piotroski F-Score | n/a |